The TTHealthWatch podcast covers two main topics: global pain levels and tertiary patents for FDA-approved drugs. It states that pain is a significant burden on population health worldwide, with a large proportion of people suffering from chronic pain. It discusses how pain levels vary between countries and regions and what factors (such as access to health care and pain medication) may influence these differences. The section on medicines discusses the so-called tertiary patents, i.e. other, later patents for already approved drugs. The podcast explains that such patents can extend the period of exclusivity of original preparations. It discusses how these patents affect the availability of generic drugs and the cost of treatment for patients and health systems. The presenters briefly comment on the clinical and policy implications of these findings.